Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1952 5
1953 1
1955 2
1956 2
1957 1
1960 4
1961 13
1962 14
1963 20
1964 15
1965 9
1966 17
1967 21
1968 22
1969 12
1970 19
1971 24
1972 18
1973 15
1974 19
1975 17
1976 28
1977 26
1978 55
1979 54
1980 45
1981 58
1982 69
1983 83
1984 81
1985 99
1986 115
1987 104
1988 114
1989 109
1990 111
1991 108
1992 127
1993 137
1994 140
1995 169
1996 176
1997 161
1998 177
1999 218
2000 224
2001 225
2002 240
2003 283
2004 293
2005 271
2006 298
2007 292
2008 338
2009 327
2010 316
2011 386
2012 385
2013 398
2014 419
2015 459
2016 477
2017 526
2018 459
2019 550
2020 661
2021 744
2022 716
2023 646
2024 305
2025 2

Text availability

Article attribute

Article type

Publication date

Search Results

11,874 results

Results by year

Filters applied: . Clear all
Page 1
Patritumab Deruxtecan (HER3-DXd), a Human Epidermal Growth Factor Receptor 3-Directed Antibody-Drug Conjugate, in Patients With Previously Treated Human Epidermal Growth Factor Receptor 3-Expressing Metastatic Breast Cancer: A Multicenter, Phase I/II Trial.
Krop IE, Masuda N, Mukohara T, Takahashi S, Nakayama T, Inoue K, Iwata H, Yamamoto Y, Alvarez RH, Toyama T, Takahashi M, Osaki A, Saji S, Sagara Y, O'Shaughnessy J, Ohwada S, Koyama K, Inoue T, Li L, Patel P, Mostillo J, Tanaka Y, Sternberg DW, Sellami D, Yonemori K. Krop IE, et al. Among authors: yamamoto y. J Clin Oncol. 2023 Dec 20;41(36):5550-5560. doi: 10.1200/JCO.23.00882. Epub 2023 Oct 6. J Clin Oncol. 2023. PMID: 37801674 Free PMC article. Clinical Trial.
Improved Cardiac Performance and Decreased Arrhythmia in Hypertrophic Cardiomyopathy With Non-β-Blocking R-Enantiomer Carvedilol.
Seo K, Yamamoto Y, Kirillova A, Kawana M, Yadav S, Huang Y, Wang Q, Lane KV, Pruitt BL, Perez MV, Bernstein D, Wu JC, Wheeler MT, Parikh VN, Ashley EA. Seo K, et al. Among authors: yamamoto y. Circulation. 2023 Nov 21;148(21):1691-1704. doi: 10.1161/CIRCULATIONAHA.123.065017. Epub 2023 Oct 18. Circulation. 2023. PMID: 37850394
Efficacy and Safety of Cilostazol in Mild Cognitive Impairment: A Randomized Clinical Trial.
Saito S, Suzuki K, Ohtani R, Maki T, Kowa H, Tachibana H, Washida K, Kawabata N, Mizuno T, Kanki R, Sudoh S, Kitaguchi H, Shindo K, Shindo A, Oka N, Yamamoto K, Yasuno F, Kakuta C, Kakuta R, Yamamoto Y, Hattori Y, Takahashi Y, Nakaoku Y, Tonomura S, Oishi N, Aso T, Taguchi A, Kagimura T, Kojima S, Taketsuna M, Tomimoto H, Takahashi R, Fukuyama H, Nagatsuka K, Yamamoto H, Fukushima M, Ihara M; COMCID Trial Investigator Group. Saito S, et al. Among authors: yamamoto y. JAMA Netw Open. 2023 Dec 1;6(12):e2344938. doi: 10.1001/jamanetworkopen.2023.44938. JAMA Netw Open. 2023. PMID: 38048134 Free PMC article. Clinical Trial.
Real-world comparative study of the efficacy of Janus kinase inhibitors in patients with rheumatoid arthritis: the ANSWER cohort study.
Hayashi S, Tachibana S, Maeda T, Yamashita M, Shirasugi I, Yamamoto Y, Yamada H, Okano T, Nishimura K, Ueda Y, Jinnno S, Saegusa J, Yamamoto W, Murata K, Fujii T, Hata K, Yoshikawa A, Ebina K, Etani Y, Yoshida N, Amuro H, Hashimoto M, Hara R, Katayama M, Okano T, Kuroda R. Hayashi S, et al. Among authors: yamamoto y. Rheumatology (Oxford). 2023 Nov 1:kead543. doi: 10.1093/rheumatology/kead543. Online ahead of print. Rheumatology (Oxford). 2023. PMID: 37924201
Unexpected Diffuse Alveolar Hemorrhage After Bronchoscopy.
Tsukida S, Watanabe S, Hongo M, Murase Y, Yamamoto Y, Kase K, Terada N, Koba H, Tambo Y, Yano S. Tsukida S, et al. Among authors: yamamoto y. Chest. 2023 Sep;164(3):e71-e74. doi: 10.1016/j.chest.2023.04.027. Chest. 2023. PMID: 37689476
Comparative pathogenicity of SARS-CoV-2 Omicron subvariants including BA.1, BA.2, and BA.5.
Tamura T, Yamasoba D, Oda Y, Ito J, Kamasaki T, Nao N, Hashimoto R, Fujioka Y, Suzuki R, Wang L, Ito H, Kashima Y, Kimura I, Kishimoto M, Tsuda M, Sawa H, Yoshimatsu K, Yamamoto Y, Nagamoto T, Kanamune J, Suzuki Y, Ohba Y; Genotype to Phenotype Japan (G2P-Japan) Consortium; Yokota I, Matsuno K, Takayama K, Tanaka S, Sato K, Fukuhara T. Tamura T, et al. Among authors: yamamoto y. Commun Biol. 2023 Jul 24;6(1):772. doi: 10.1038/s42003-023-05081-w. Commun Biol. 2023. PMID: 37488344 Free PMC article.
Postnatal expression of CD38 in astrocytes regulates synapse formation and adult social memory.
Hattori T, Cherepanov SM, Sakaga R, Roboon J, Nguyen DT, Ishii H, Takarada-Iemata M, Nishiuchi T, Kannon T, Hosomichi K, Tajima A, Yamamoto Y, Okamoto H, Sugawara A, Higashida H, Hori O. Hattori T, et al. Among authors: yamamoto y. EMBO J. 2023 Aug 1;42(15):e111247. doi: 10.15252/embj.2022111247. Epub 2023 Jun 26. EMBO J. 2023. PMID: 37357972 Free article.
Identifying high-grade serous ovarian carcinoma-specific extracellular vesicles by polyketone-coated nanowires.
Yokoi A, Ukai M, Yasui T, Inokuma Y, Hyeon-Deuk K, Matsuzaki J, Yoshida K, Kitagawa M, Chattrairat K, Iida M, Shimada T, Manabe Y, Chang IY, Asano-Inami E, Koya Y, Nawa A, Nakamura K, Kiyono T, Kato T, Hirakawa A, Yoshioka Y, Ochiya T, Hasegawa T, Baba Y, Yamamoto Y, Kajiyama H. Yokoi A, et al. Among authors: yamamoto y. Sci Adv. 2023 Jul 7;9(27):eade6958. doi: 10.1126/sciadv.ade6958. Epub 2023 Jul 7. Sci Adv. 2023. PMID: 37418532 Free PMC article.
Mutational spectrum of TP53 gene correlates with nivolumab treatment efficacy in advanced gastric cancer (TP53MUT study).
Ando K, Nakamura Y, Kitao H, Shimokawa M, Kotani D, Bando H, Nishina T, Yamada T, Yuki S, Narita Y, Hara H, Ohta T, Esaki T, Hamamoto Y, Kato K, Yamamoto Y, Minashi K, Ohtsubo K, Izawa N, Kawakami H, Kato T, Satoh T, Okano N, Tsuji A, Yamazaki K, Yoshino T, Maehara Y, Oki E. Ando K, et al. Among authors: yamamoto y. Br J Cancer. 2023 Oct;129(6):1032-1039. doi: 10.1038/s41416-023-02378-9. Epub 2023 Aug 2. Br J Cancer. 2023. PMID: 37532830
11,874 results
You have reached the last available page of results. Please see the User Guide for more information.